Finding asthmatics suitable for omalizumab therapy in a district hospital Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013
Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting Source: International Congress 2017 – Asthma management Year: 2017
Does having specialist asthma nurses improve adherence to national asthma guidelines? A comparison between two UK district general hospitals Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015
Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Reason for non-compliance to inhaled medications among adult patients of asthma and COPD attending outpatient department in a tertiary care hospital Source: International Congress 2016 – Asthma management in primary care Year: 2016
What is new in paediatric asthma? Source: Annual Congress 2006 - Paediatric year in review Year: 2006
A virtual asthma clinic for children: Improved asthma control, less hospital visits Source: International Congress 2015 – Paediatric asthma and allergy: e-health in management Year: 2015
Follow-up of patients with severe eosinophilic asthma receiving mepolizumab for one year in specialized asthma clinics in Greece. Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020
Omalizumab in severe allergic asthma: a 4-year real world experience, Fife, Scotland Source: International Congress 2017 – Asthma management Year: 2017
Emergency visits for asthma: asthma exacerbations or poor asthma control? Source: Eur Respir J 2004; 24: Suppl. 48, 598s Year: 2004
How are we managing our asthmatic patients? Asthma diagnosis and treatment in an urban primary care practice Source: Eur Respir J 2004; 24: Suppl. 48, 85s Year: 2004
Cost of asthma in patients treated with national asthma guideline in Turkey Source: Eur Respir J 2003; 22: Suppl. 45, 481s Year: 2003
Omalizumab: therapeutic approach to asthma and comorbidities Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Effectiveness of pharmacist intervention for asthma control improvement Source: Eur Respir J 2008; 31: 790-799 Year: 2008
Asthma in pre-schoolers: difficult to treat Source: Annual Congress 2005 - Asthma in the preschool child Year: 2005
If the global initiative for asthma (GINA) reflected on the asthma therapy in Croatia? Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
Treatment of asthma exacerbations managed in primary care in Spain Source: Eur Respir J 2001; 18: Suppl. 33, 235s Year: 2001
Montelukast in paediatric asthma: where we are now and what still needs to be done? Source: International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?" Year: 2014
The burden of paediatric asthma: economic and familiar Source: Eur Respir Mon 2012; 56: 71-81 Year: 2012
Budesonide/formoterol maintenance and reliever therapy for asthma in general practice: is it cost-effective? Source: Annual Congress 2008 - Diagnosing, monitoring and treating respiratory diseases in primary care Year: 2008